Dr. Haleh Hamedifar is one of the most renowned leaders in the biopharmaceutical industry in the MENA region. Her leadership has transformed CinnaGen from a team of twelve people active in diagnostic kit development and manufacturing to a global biopharma powerhouse with sales in more than 40 countries and +5,000 employees. The group of companies has had a major impact on increasing access to advanced therapeutics, saving billions of dollars for the healthcare systems while expanding treatment options for patients and those who care for them.